Zoetis (ZTS) Cash from Investing Activities Growth (3y) (2015 - 2026)
Analysis
Zoetis (ZTS) Cash from Investing Activities Growth (3y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.64 Bn | 40.44 Bn | 779.09 Mn | 2.46% |
| 2 | Zoetis | 30.58 Bn | 28.90 Bn | 1.05 Bn | -55.36% |
| 3 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | -36.76% |
| 4 | Phibro Animal Health | 1.49 Bn | 1.41 Bn | 134.40 Mn | -16.96% |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 74.81 Mn | 67.72 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -55.36% |
| Mar 31, 2026 | 26.15% |
| Dec 31, 2025 | 27.63% |
| Sep 30, 2025 | -10.43% |
| Jun 30, 2025 | -1.46% |
| Mar 31, 2025 | -19.82% |
| Dec 31, 2024 | 42.40% |
| Sep 30, 2024 | -16.01% |
| Jun 30, 2024 | 1.71% |
| Mar 31, 2024 | -27.64% |
| Dec 31, 2023 | -5.86% |
| Sep 30, 2023 | -15.92% |
| Jun 30, 2023 | 21.28% |
| Mar 31, 2023 | -55.90% |
| Dec 31, 2022 | -27.16% |
| Sep 30, 2022 | 15.97% |
| Jun 30, 2022 | -50.97% |
| Mar 31, 2022 | -72.47% |
| Dec 31, 2021 | -24.27% |
| Sep 30, 2021 | 61.92% |